DEA Emerging Threat Report: 2017 Annual
- NPS, excluding fentanyl and fentanyl-related compounds, accounted for approximately 4% of the exhibits seized in 2017 and analyzed by the DEA laboratory system in 2017.
- FUB-AMB was the most reported synthetic cannabinoid and N-ethylpentylone was the most reported cathinone in 2017.
- Fentanyl and fentanyl-related compounds represented approximately 7% of the exhibits seized in 2017 and analyzed by the DEA laboratory system in 2017.
- Fentanyl and furanyl fentanyl were the most commonly reported opioids.
- There were 15 substances reported for the first time in CY2017, meaning they have not been encountered for at least the last three years. This equates to one new substance every three weeks. It should be noted that as backlogged samples are analyzed, the date of the first encounter may change.
- Most notably, approximately 55% of the opioids identified in CY2017 were seized and identified for the first time in CY2017.
- There was a significant increase in the number of NPS benzodiazepinesreported in CY2017. The most prevalent NPS benzodiazepine in CY2017 was etizolam.
Click for an archive of quarterly and annual threat reports